Corrigendum to 'A randomized controlled, dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults'. [Int. Immunopharmacol. 75 (2019) 105807]

Affiliations

¹ Department of Pharmacy, Peking University People's Hospital, Beijing, China; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
² United-Power Pharma Tech Co., Ltd., Beijing, China.
³ Department of Pharmacy, Peking University People's Hospital, Beijing, China; Xuzhou Medical University, Xuzhou, China.
⁴ Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
⁵ Department of Pharmacy, Peking University People's Hospital, Beijing, China.
⁶ Department of Pharmacy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
⁷ Aix-Marseille University, 27 bd Jean Moulin, 13385 Marseille Cedex 05, France.
⁸ The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.
⁹ Shenyang Sunshine Pharmaceutical Co., Ltd, Shenyang, China.
¹⁰ State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China; National Engineering Research Center for Protein Drugs, Beijing, China. Electronic address: songhf@nic.bmi.ac.cn.
¹¹ Department of Pharmacy, Peking University People's Hospital, Beijing, China. Electronic address: phaseistudy@163.com.

Published Erratum

Qi Wang et al. Int Immunopharmacol. 2020 Oct.

. 2020 Oct:87:106874.

doi: 10.1016/j.intimp.2020.106874. Epub 2020 Aug 10.

¹ Department of Pharmacy, Peking University People's Hospital, Beijing, China; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
² United-Power Pharma Tech Co., Ltd., Beijing, China.
³ Department of Pharmacy, Peking University People's Hospital, Beijing, China; Xuzhou Medical University, Xuzhou, China.
⁴ Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
⁵ Department of Pharmacy, Peking University People's Hospital, Beijing, China.
⁶ Department of Pharmacy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
⁷ Aix-Marseille University, 27 bd Jean Moulin, 13385 Marseille Cedex 05, France.
⁸ The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.
⁹ Shenyang Sunshine Pharmaceutical Co., Ltd, Shenyang, China.
¹⁰ State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China; National Engineering Research Center for Protein Drugs, Beijing, China. Electronic address: songhf@nic.bmi.ac.cn.
¹¹ Department of Pharmacy, Peking University People's Hospital, Beijing, China. Electronic address: phaseistudy@163.com.

No abstract available

Erratum for

A randomized controlled dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults.
Wang Q, Xie X, Su F, Wang J, Chen S, Wang Q, Jiang D, Wang Y, Zhang T, Liu C, Han M, Tao T, Wu Q, Xi N, Li Z, Song H, Fang Y. Wang Q, et al. Int Immunopharmacol. 2019 Oct;75:105807. doi: 10.1016/j.intimp.2019.105807. Epub 2019 Aug 12. Int Immunopharmacol. 2019. PMID: 31416011 Clinical Trial.